Advised Vitargent, a Hong Kong biotech unicorn, on advising a start-up biotech in devising IP strategies in fortifying their core technologies to pave its way in future licensing transactions.
-
Partner
Advised Vitargent, a Hong Kong biotech unicorn, on advising a start-up biotech in devising IP strategies in fortifying their core technologies to pave its way in future licensing transactions.